What are the key factors in China's Pharma Market? | |
A growing chronic disease burden, aging population and strong demand for patented innovative drugs, driven by rising incomes, are all opportunities for this lucrative market - forecast to be worth $172.5 bn by 2023. However, local competition and financial sustainability of the healthcare system are among the challenges that the market is currently facing. | | | Chinese Pharma Market in Numbers | | 7% CAGR
estimated
in 2018-2022
| | | | $172.5 bn by 2023
estimated
pharma market value | | | | | 1.43 billion
population
(1st globally) | | | | | | With the 20 years of deep indulgence in the Chinese pharma industry, CPhI China has prepared you an infograph with key factors and analysis of the market.
Download our infographic here to catch the latest insights! | | | Tap into the Chinese pharma market with
CPhI & P-MEC China 2020 | | CPhI & P-MEC China 2020 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. With its colocated shows FDF, NEX, P-MEC, LABWorld, and InnoPack China, CPhI & P-MEC China serves as a ONE-STOP SHOP pharmaceutical platform in Asia. | | | | | Meet the entire pharmaceutical chain in 1 location | | | |
No comments:
Post a Comment